Involvement of p38 MAPK in reactive astrogliosis induced by ischemic stroke
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Reactive astrogliosis is an essential feature of astrocytic response to all forms of central nervous system (CNS) injury and disease, which may benefit or harm surrounding neural and non-neural cells. Despite extensive study, its molecular triggers remain largely unknown in term of ischemic stroke. In the current study we investigated the role p38 mitogen-activated protein kinase (MAPK) in astrogliosis both in vitro and in vivo. In a mouse model of middle cerebral artery occlusion (MCAO), p38 MAPK activation was observed in the glia scar area, along with increased glial fibrillary acidic protein (GFAP) expression. In primary astrocyte cultures, hypoxia and scratch injury-induced astrogliosis was attenuated by both p38 inhibition and knockout of p38 MAPK. In addition, both knockout and inhibition of p38 MAPK also reduced astrocyte migration, but did not affect astrocyte proliferation. In a mouse model of permanent MCAO, no significant difference in motor function recovery and lesion volume was observed between conditional GFAP/p38 MAPK knockout mice and littermates. While a significant reduction of astrogliosis was observed in the GFAP/p38 knockout mice compared with the littermates. Our findings suggest that p38 MAPK signaling pathway plays an important role in the ischemic stroke-induced astrogliosis and thus may serve as a novel target to control glial scar formation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular dissection of reactive astrogliosis and glial scar formation
Sofroniew, M. V. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2009.08.002 · Cited by 2,594 · cited 7×
“Compelling evidence has indicated that reactive astrogliosis is a complex process either through loss of essential functions performed by astrocytes or by gain of detrimental effects after activation (Sofroniew, 2009).”
BackgroundInfluentialBush, T. G., Puvanachandra, N., Horner, C. H., Polito, A., Ostenfeld, T., Svendsen, C. N., Mucke, L., Johnson, M. H., & Sofroniew, M. V. (1999) · Neuron · doi:10.1016/s0896-6273(00)80781-3 · Cited by 1,116 · cited 2×
“Cell type-specific and temporal control of astrocyte deletion has been applied in combination with various forms of experimental CNS insults, including forebrain stab injury (Bush et al., 1999), spinal cord injury (Faulkner et al.”
BackgroundInnate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034 · cited 1×
“Introduction Despite the perception as an immune privilege site, immune responses in the central nervous system (CNS) are common which can be mediated by resident microglia, astrocyte and infiltrating peripheral immune cells (Ransohoff and Brown, 2012).”
BackgroundSTAT3 is a Critical Regulator of Astrogliosis and Scar Formation after Spinal Cord Injury
Herrmann, J. E., Imura, T., Song, B., Qi, J., Ao, Y., Nguyen, T. K., Korsak, R. A., Takeda, K., Akira, S., & Sofroniew, M. V. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1709-08.2008 · Cited by 958 · cited 3×
“Studies indicate that reactive astrogliosis may exert both beneficial and detrimental effects in a context-dependent manner regulated by specific molecular signaling cascades, including signal transducers and activators of transcription (STAT3), nuclear factor kappaB (NFκB), and mTOR signaling after spinal cord injury…”
BackgroundMethodProtective Role of Reactive Astrocytes in Brain Ischemia
Li, L., Lundkvist, A., Andersson, D., Wilhelmsson, U., Nagai, N., Pardo, A. C., Nodin, C., Ståhlberg, A., Aprico, K., Larsson, K., et al. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600546 · Cited by 505 · cited 1×
“Double deletion of GFAP and vimentin reduces astrogliosis and increases axon regeneration, but exacerbates ischemic stroke (Li et al., 2008) by increasing lesion size and worsening outcome.”
Backgroundp38 and ERK1/2 Coordinate Cellular Migration and Proliferation in Epithelial Wound Healing
Sharma, G.-D., He, J., & Bazan, H. E. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302650200 · Cited by 337 · cited 1×
“There is an indication that p38 MAPK is involved in the cellular migration in epithelial wound healing process without affecting proliferation (Sharma et al., 2003).”
BackgroundMunoz, L., Ranaivo, H. R., Roy, S. M., Hu, W., Craft, J. M., McNamara, L. K., Chico, L. W., Van Eldik, L. J., & Watterson, D. M. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-21 · Cited by 224 · cited 1×
“P A A uthor M anuscript disease mouse model, p38 MAPK inhibitor has been shown to suppress brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits (Munoz et al., 2007).”
Cited by
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Self-citationCurrent advances in ischemic stroke research and therapies
Barthels, D., & Das, H. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.012 · Cited by 709
The Role of Astrocytes in CNS Inflammation
Giovannoni, F., & Quintana, F. J. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.07.007 · Cited by 651
The role of astrocytes in oxidative stress of central nervous system: A mixed blessing
Chen, Y., Qin, C., Huang, J., Tang, X., Liu, C., Huang, K., Xu, J., Guo, G., Tong, A., & Zhou, L. (2020) · Cell Proliferation · doi:10.1111/cpr.12781 · Cited by 307
Hyperglycemia Alters Astrocyte Metabolism and Inhibits Astrocyte Proliferation
Li, W., Roy Choudhury, G., Winters, A., Prah, J., Lin, W., Liu, R., & Yang, S.-H. (2018) · Aging and disease · doi:10.14336/ad.2017.1208 · Cited by 92
“Primary astrocytes were prepared according to previous study with modifications [23, 24].”
MethodSelf-citationStress-Activated Protein Kinases in Spinal Cord Injury: Focus on Roles of p38
Kasuya, Y., Umezawa, H., & Hatano, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030867 · Cited by 54
Zheng, Y., Huang, Z., Xu, J., Hou, K., Yu, Y., Lv, S., Chen, L., Li, Y., Quan, C., & Chi, G. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02345-6 · Cited by 24
Pybus, A. F., Bitarafan, S., Brothers, R. O., Rohrer, A., Khaitan, A., Moctezuma, F. R., Udeshi, K., Davies, B., Triplett, S., Griffin, M. N., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03128-1 · Cited by 12
Metadata
- Authors
- Roy Choudhury, G., Ryou, M.-G., Poteet, E., Wen, Y., He, R., Sun, F., Yuan, F., Jin, K., & Yang, S.-H.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2014-03
- Volume
- 1551
- Pages
- 45-58
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2110644363
- Cited by
- 121
- References
- 7
- FWCI
- 3.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.